| Gene ID | 1588 |
| Symbol | CYP19A1 |
| Synonymous | ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM |
| Full name | cytochrome P450, family 19, subfamily A, polypeptide 1 |
| Gene description | aromatase|cytochrome P-450AROM|cytochrome P450 19A1|cytochrome P450, subfamily XIX (aromatization of androgens)|estrogen synthase|estrogen synthetase|flavoprotein-linked monooxygenase|microsomal monooxygenase |
| Cytoband | 15q21.1 |
| Gene type | protein-coding |
| Synonymous | MIM:107910; HGNC:HGNC:2594; Ensembl:ENSG00000137869; HPRD:00488; Vega:OTTHUMG00000131747 |
Pathways and Diseases | Detail |
|---|---|
Pathway | Steroid hormone biosynthesis;KEGG PATHWAY;hsa00140 |
Pathway | Metabolic pathways;KEGG PATHWAY;hsa01100 |
Pathway | Biological oxidations;Reactome;REACT:13433 |
Pathway | Metabolism of lipids and lipoproteins;Reactome;REACT:22258 |
Pathway | estrogen biosynthesis;BioCyc;PWY66-380 |
Pathway | Estrogen biosynthesis;PID Reactome;500777 |
Pathway | Endogenous sterols;PID Reactome;500195 |
Pathway | Hormone biosynthesis;Reactome;REACT:15314 |
Disease | Height;NHGRI |
Disease | menopause;GAD |
Disease | adult male height;GAD |
Disease | Polyarthritis;FunDO |
Disease | Uterine disease;FunDO |
Disease | Breast cancer;FunDO |
Disease | DEVELOPMENTAL;GAD |
Disease | Osteoporosis, Postmenopausal;GAD |
Disease | Prostate cancer;FunDO |
Disease | endometriosis;GAD |
Disease | Aromatase excess syndrome;OMIM |
Disease | fractures;GAD |
Disease | prostate cancer;GAD |
Disease | hormone disturbance;GAD |
Disease | Infiltrating cancer;FunDO |
Disease | Urogenital abnormalities;FunDO |
Disease | METABOLIC;GAD |
Disease | bone density;GAD |
Disease | fractures, vertebral;GAD |
Disease | REPRODUCTION;GAD |
Disease | CANCER;GAD |
Disease | Adrenal gland tumor;FunDO |
Disease | Female pseudohermaphroditism;GAD |
Disease | Endometriosis;FunDO |
Disease | height;GAD |
Disease | Hypertension;FunDO |
Disease | bone mass;GAD |
Disease | diabetes, type 2 insulin metabolic syndrome;GAD |
Disease | aromatase excess syndrome;GAD |
Disease | Osteoporosis;FunDO |
Disease | breast cancer;GAD |
Disease | Ovarian cancer;FunDO |
Disease | Obesity;FunDO |
Disease | endometrial cancer;GAD |
Disease | Aromatase deficiency;OMIM |
Disease | prostate carcinoma;GAD |
Disease | Hyperandrogenism;GAD |
Sequence Information | |
|---|---|
Nucleotide Sequence | >1588 : length: 4531 GGGAGTTTCTGGAGGGCTGAACACGTGGAGGCAAACAGGAAGGTGAAGAAGAACTTATCCTATCAGGACGGAAGGTCCTGTGCTCGGGATCTTCCAGACGTCGCGCGGTGTCAGAAACCC TGTGGTGAAATTCAGCCTGTGGATTCCAGAAATTTGGAGTGTTCTTGGGGGGAAAAATCCGCACACACAAAGCAACATTTGGAAATCCCTGTGGACTCTAAATTGCCCCCTCTGAGGTCA AGGAACACAAGATGGTTTTGGAAATGCTGAACCCGATACATTATAACATCACCAGCATCGTGCCTGAAGCCATGCCTGCTGCCACCATGCCAGTCCTGCTCCTCACTGGCCTTTTTCTCT TGGTGTGGAATTATGAGGGCACATCCTCAATACCAGGTCCTGGCTACTGCATGGGAATTGGACCCCTCATCTCCCACGGCAGATTCCTGTGGATGGGGATCGGCAGTGCCTGCAACTACT ACAACCGGGTATATGGAGAATTCATGCGAGTCTGGATCTCTGGAGAGGAAACACTCATTATCAGCAAGTCCTCAAGTATGTTCCACATAATGAAGCACAATCATTACAGCTCTCGATTCG GCAGCAAACTTGGGCTGCAGTGCATCGGTATGCATGAGAAAGGCATCATATTTAACAACAATCCAGAGCTCTGGAAAACAACTCGACCCTTCTTTATGAAAGCTCTGTCAGGCCCCGGCC TTGTTCGTATGGTCACAGTCTGTGCTGAATCCCTCAAAACACATCTGGACAGGTTGGAGGAGGTGACCAATGAATCGGGCTATGTGGACGTGTTGACCCTTCTGCGTCGTGTCATGCTGG ACACCTCTAACACGCTCTTCTTGAGGATCCCTTTGGACGAAAGTGCTATCGTGGTTAAAATCCAAGGTTATTTTGATGCATGGCAAGCTCTCCTCATCAAACCAGACATCTTCTTTAAGA TTTCTTGGCTATACAAAAAGTATGAGAAGTCTGTCAAGGATTTGAAAGATGCCATAGAAGTTCTGATAGCAGAAAAAAGACGCAGGATTTCCACAGAAGAGAAACTGGAAGAATGTATGG ACTTTGCCACTGAGTTGATTTTAGCAGAGAAACGTGGTGACCTGACAAGAGAGAATGTGAACCAGTGCATATTGGAAATGCTGATCGCAGCTCCTGACACCATGTCTGTCTCTTTGTTCT TCATGCTATTTCTCATTGCAAAGCACCCTAATGTTGAAGAGGCAATAATAAAGGAAATCCAGACTGTTATTGGTGAGAGAGACATAAAGATTGATGATATACAAAAATTAAAAGTGATGG AAAACTTCATTTATGAGAGCATGCGGTACCAGCCTGTCGTGGACTTGGTCATGCGCAAAGCCTTAGAAGATGATGTAATCGATGGCTACCCAGTGAAAAAGGGGACAAACATTATCCTGA ATATTGGAAGGATGCACAGACTCGAGTTTTTCCCCAAACCCAATGAATTTACTCTTGAAAATTTTGCAAAGAATGTTCCTTATAGGTACTTTCAGCCATTTGGCTTTGGGCCCCGTGGCT GTGCAGGAAAGTACATCGCCATGGTGATGATGAAAGCCATCCTCGTTACACTTCTGAGACGATTCCACGTGAAGACATTGCAAGGACAGTGTGTTGAGAGCATACAGAAGATACACGACT TGTCCTTGCACCCAGATGAGACTAAAAACATGCTGGAAATGATCTTTACCCCAAGAAACTCAGACAGGTGTCTGGAACACTAGAGAAGGCTGGTCAGTACCCACTCTGGAGCATTTCTCA TCAGTAGTTCACATACAAATCATCCATCCTTGCCAATAGTGTCATCCTCACAGTGAACACTCAGTGGCCCATGGCATTTTATAGGCATACCTCCTATGGGTTGTCACCAAGCTAGGTGCT ATTTGTCATCTGCTCCTGTTCACACCAGAGAACCAGGCTACAAGAGAAAAAGCAGAGGCCAAGAGTTTGAGGGAGAAATAGTCGGTGAAGAAACCGTATCCATAAAGACCCGATTCCACC AAATGTGCTTTGAGAAGGATAGGCCTTCATTAACAAAATGTATGTCTGGTTCCCCAGTAGAGCTCTACTGCCTCAACCCAAGGGGATTTTTATGTCTGGGGCAGAAACACTCAAGTTGAT TAGAAAGACCAGGCCAATGTCAGGGTACCTGGGGCCAAACCCACCTGCTAGTGTGAATTAAAGTACTTTAATTTTGTTTTCTGTGGAGGTGGAAAAGCAACATTCATAGTCTTTGGAGAA ATGCTTAGAAATTCAGCATTTGACCCTTGCTGTGAATTAAGCCCAATTAATTCCTGTTTGTCTACATATGATCTGTCTGTGGCAAAAGTTTAATCAGAGGAAATTCTTTCCCAGTCTGTC GATTTATGCCTCAGCCACTTGCCTGTGCTACAATTCATTGTGTTACCTGTAGATTCAGGTAATACAAACTATATATAATCATCAAGTAATACAAACTAATTTAGTAATAGCCTGGGTTAA GTATTATTAGGGCCCTGTGTCTGCTGTAGAAAAAAAAATTCACATGATGCACTTCAAATTCAAATAAAAATCCTTTTGGCATGTTCCCATTTTTGCTTAGCTCAATTAGTGTGGCTAACC AAGAGATAACTGTAAATGTGACATTGATTTGCTCTTACTACAGCTTCAGTGATTGGGGGAGGAAAAGTCCCAACCCAATGGGCTCAAACTTCTAAGGGGTACTCCTCTCATCCCCTTATC CTTCTCCCTCGACATTTTCTCCCTCTTTCTTCCCATGACCCCAAAGCCAAGGGCAACAGATCAGTAAAGAACGTGGTCAGAGTAGAACCCCTGAAGTATTTTTTAATCCTACCTCAAAAT TTAACAGTTACCTGAGAGATTTAACATTATCTAGTTCATTGAATCATTGTATGTGGTCATGGATAAATTGCACACCTTGGAATTCGCTTTCTAAAGGAAATCAAATGAATGGAGGAACTT TCCAAACACCACTTTACTTGTGTTATATAGCCAATATAACTATCTCTACTGAATGTCATTGAAAAACTAAAAAATTAAACTTATTTACAAATAGGTAAATATTTGTCATTGAATCCATTG CCATCCCATTTGACTGTTCTTTTCATCCTACTGTCTAGTAATAAGCTGAGTATAAGATGACAGTGTAATCTCCCTGAAAGCAGGAGCTACTTTCTTTCTTTTGTAATCTATTTCCATCCC CATTTCCCTGTCCTGTCTCCCTGTATTCACTCCCAAGCTCAGTTCTGAATAGACATTCCTGCTCAGAGATACTCCCAACTGATGCAGAAACCAAATAAAGAGGTAGGTATTCCAAGAATT CAAGAATGGACATTAGTAAAGAATAAAACATTTATTTGAGCTTGGAATTATTTGGATCATCTATATGGCCTAAAAATATATGGACTATGCCTGTGTACCTGAATACGTATGTAGTCAGGT CAAGACAATCATCCAAATAACTTAGACCCCTAAAAGCAAGGCCAGGATTTGCAATTTAATGTGTCCCAATTAATTCACTTGAAAATTAGTAACACTCTGTTTACGTTGCCTCTGGCTGGA GCTGCATGGTGGAAGAAGCCCAACTTTGGATCCATGTACTTCACCCATCCAATACTCTTGGGACATTTATGTGTATTTTATCTGTATATATGAAGCCAATGTCTATGTCTACACAGTCAA AGTGAAATGCATGTTTGATATAGCTGTACATAGATATCTATTTTGCAGGTACAAAAATATCCTGGGGGAAAACTGGGAGTGGAAGGGTGGGGGGTGGGAGTGAGGGACATGGGGGAGGGA CAGGAAGAGGAGAAGTGTTGGTTTGAACGATCCAAGCAAACTCTCCCAGAATCAAATTACCTGGGTAGTTGTTCAACTTTTCACTCTGCTTAGCCTGTATAGACAAACCCCATATATTTG TAGAGGCTTGGCCTTGGAATTCTGGAATACCATTGGCTTTTCAGTAGGCTGATGAACACATTTTGAAAATTCTATTATCTTCAGAATTTTGCCCCATTGTTAAGTGCTTAACCGTCACTC TTGAATGTGCAATGTGCTGTGGATTCCATTTTCATCAGTTCTGAAAGAACTGCAATGTGTAAATTATCAGTGAAATGCATGCATATAAGGGCTCTATCATTATCAAATTGTAAGGACAAT TGTACCCTTCTATATCTTTGGGCATGCTAGACACCCCCATGCCTTCATTGAGATCCCATTTTCCCCCTCTCAAGTGGAAAATAATCACATCCAGCAAGCTCTCTCATTATTGAGAAATAC CATTTGGAAATTGCCACTTTTTATTCCTAAGCAGCACCTTTCACTGTTCATGATGCTAATGTTCCACAAAAGCATGTGCCATTGGCCCACTGAAGGATAGAGGGACCCTTTTCAATCTAT ATCAGCTGGGCTCTGGGACTGAATCTCTCACCTATTCTTGCAGAAAGACATACTAATTAAACCTTGTCAAAGTAAAAAAAAAAAAAAAAAA |
Protein Sequence | >1588 : length: 503 MVLEMLNPIHYNITSIVPEAMPAATMPVLLLTGLFLLVWNYEGTSSIPGPGYCMGIGPLISHGRFLWMGIGSACNYYNRVYGEFMRVWISGEETLIISKSSSMFHIMKHNHYSSRFGSKL GLQCIGMHEKGIIFNNNPELWKTTRPFFMKALSGPGLVRMVTVCAESLKTHLDRLEEVTNESGYVDVLTLLRRVMLDTSNTLFLRIPLDESAIVVKIQGYFDAWQALLIKPDIFFKISWL YKKYEKSVKDLKDAIEVLIAEKRRRISTEEKLEECMDFATELILAEKRGDLTRENVNQCILEMLIAAPDTMSVSLFFMLFLIAKHPNVEEAIIKEIQTVIGERDIKIDDIQKLKVMENFI YESMRYQPVVDLVMRKALEDDVIDGYPVKKGTNIILNIGRMHRLEFFPKPNEFTLENFAKNVPYRYFQPFGFGPRGCAGKYIAMVMMKAILVTLLRRFHVKTLQGQCVESIQKIHDLSLH PDETKNMLEMIFTPRNSDRCLEH |